IRIS
BONAVITA, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.300
NA - Nord America 9.193
AS - Asia 6.550
SA - Sud America 1.113
Continente sconosciuto - Info sul continente non disponibili 503
AF - Africa 101
OC - Oceania 17
AN - Antartide 1
Totale 32.778
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 9.546
US - Stati Uniti d'America 8.970
SG - Singapore 2.274
IT - Italia 1.851
CN - Cina 1.496
IE - Irlanda 1.397
HK - Hong Kong 995
BR - Brasile 908
VN - Vietnam 735
GB - Regno Unito 619
DE - Germania 518
UA - Ucraina 426
KR - Corea 275
IN - India 250
SE - Svezia 170
FR - Francia 160
TR - Turchia 149
FI - Finlandia 142
JP - Giappone 133
GR - Grecia 121
AT - Austria 104
CA - Canada 103
AR - Argentina 77
MX - Messico 60
NL - Olanda 55
BD - Bangladesh 51
BE - Belgio 40
EC - Ecuador 34
CO - Colombia 31
PL - Polonia 30
IQ - Iraq 26
ES - Italia 24
ID - Indonesia 22
ZA - Sudafrica 22
PK - Pakistan 21
EG - Egitto 19
VE - Venezuela 19
MA - Marocco 18
CZ - Repubblica Ceca 17
AU - Australia 15
SA - Arabia Saudita 14
IL - Israele 13
PY - Paraguay 13
CH - Svizzera 12
JM - Giamaica 12
CL - Cile 11
IR - Iran 11
PE - Perù 11
UZ - Uzbekistan 11
CR - Costa Rica 10
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
KE - Kenya 8
LT - Lituania 8
KZ - Kazakistan 7
PH - Filippine 7
RO - Romania 7
RS - Serbia 7
TH - Thailandia 7
UY - Uruguay 7
DZ - Algeria 6
HN - Honduras 6
JO - Giordania 6
PA - Panama 6
AZ - Azerbaigian 5
EE - Estonia 5
EU - Europa 5
TT - Trinidad e Tobago 5
ET - Etiopia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
IS - Islanda 4
KG - Kirghizistan 4
LU - Lussemburgo 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
MD - Moldavia 3
NI - Nicaragua 3
PR - Porto Rico 3
SC - Seychelles 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
HT - Haiti 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
Totale 32.254
Salva come PNG Salva come JPEG
Città #
Moscow 3.362
Dublin 1.395
San Jose 1.316
Santa Clara 981
Hong Kong 974
Singapore 881
Ashburn 757
Jacksonville 641
Chandler 583
Council Bluffs 560
Seoul 269
Ho Chi Minh City 267
Hefei 260
Milan 226
Beijing 212
Princeton 208
Dallas 180
Hanoi 168
Ann Arbor 160
Roxbury 159
Medford 147
Bremen 142
Naples 135
New York 135
Bengaluru 127
Boardman 118
Caserta 116
Los Angeles 114
The Dalles 107
Rome 95
Munich 91
Vienna 84
São Paulo 73
Cambridge 71
Wilmington 65
Memphis 63
Woodbridge 57
San Mateo 55
Miano 51
Des Moines 46
Da Nang 44
Atlanta 43
Nanjing 43
Brussels 39
Kochi 39
Phoenix 38
Norwalk 37
Orem 35
Chicago 34
Nuremberg 34
Napoli 33
Tokyo 32
Jinan 29
San Francisco 28
Redhill 27
Warsaw 27
Belo Horizonte 26
Brasília 26
Haiphong 26
Brooklyn 24
Denver 24
Frankfurt am Main 24
Shenyang 24
Helsinki 23
London 23
Mexico City 22
Rio de Janeiro 22
Toronto 22
Guangzhou 21
Houston 21
Turin 21
Montreal 20
Redwood City 20
Tianjin 20
Stockholm 19
Buffalo 18
Falkenstein 18
Chennai 17
Boston 16
Newark 16
Bologna 15
Aversa 14
Hebei 14
Shanghai 14
Curitiba 13
Genoa 13
Hangzhou 13
Lappeenranta 13
Manchester 13
Mountain View 13
Nanchang 13
Turku 13
Amsterdam 12
Biên Hòa 12
Campinas 12
Florence 12
Hải Dương 12
Lanzhou 12
Padova 12
Porto Alegre 12
Totale 16.783
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 676
Spazi di Virchow Robin e sclerosi multipla: studio con risonanza magnetica ad Alto Campo 3 Tesla 280
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 220
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 217
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 211
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 210
Advantages of QBI in TBSS analyses. 196
Preliminary data from a study on clinical and neuroradiological correlations between cerebral microbleeds and different subtypes of mild cognitive impairment 188
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 187
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 187
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 185
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 184
Telemedicine application to headache: a critical review 181
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 179
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 179
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 178
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 177
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 177
Repetitive Transcranial Magnetic Stimulation (rTMS) of Dorsolateral Prefrontal Cortex May Influence Semantic Fluency and Functional Connectivity in Fronto-Parietal Network in Mild Cognitive Impairment (MCI) 175
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 172
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 171
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 169
An exploration of anger phenomenology in multiple sclerosis 167
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 166
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 166
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 166
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 164
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 161
Is the pathology of posterior cortical atrophy clinically predictable? 160
Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI) 160
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 160
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 159
Apparently isolated CNS involvement in Erdheim-Chester disease: Case report 159
Aspetti neuroradiologici inusuali in un caso di leucoencefalite multifocale progressiva in paziente non HIV positivo 159
Il Ruolo della RM nella definizione morfologica dell'invecchiamento cerebrale. 156
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS) 156
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 155
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 154
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 153
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 152
Whole-brain propagation delays in multiple sclerosis, a combined tractography - magnetoencephalography study 150
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 150
Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions-A Systematic Review 149
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 149
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 149
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 149
Chronic acquired hepatocerebral degeneration: a case report. 148
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 148
Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project. 147
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study. 147
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 147
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 146
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 146
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 146
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 144
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 144
The role of diet in multiple sclerosis: A review 143
e-Health and multiple sclerosis: An update 143
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 141
Signs and symptoms of COVID-19 in patients with multiple sclerosis 141
Apolipoprotein E genotype does not influence the progression of multiple sclerosis 141
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 140
Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis 140
Disability assessment using Google Maps 140
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate 138
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 137
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 137
Anti-GM1 ganglioside antibodies in Parkinson's disease 136
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 136
Proton spectroscopic imaging - Principles and clinical applications in neurology 135
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 135
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 135
A real-world study of alemtuzumab in a cohort of Italian patients 135
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition 135
Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 tesla in the delineation of glioblastomas: Preliminary results 133
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 133
La terapia della sclerosi multipla 132
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 132
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 132
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 131
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis 131
Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis 131
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 130
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 130
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 130
Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest 129
MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain 129
MAlattie infettive (meningiti, encefaliti, infezione da HIV, encefalopatie spongiformi) 129
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 128
Pain, quality of life, and religiosity in people with multiple sclerosis 128
Clinical implications for the association of psoriasis and multiple sclerosis: an observational study 128
Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent 128
A disease in the age of the web: How to help people with Multiple Sclerosis in social media interaction. 128
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 128
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 127
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 126
Assessing disability and relapses in multiple sclerosis on tele-neurology 126
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 125
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study 125
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. 125
Totale 15.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.289 0 0 0 54 428 45 35 46 62 98 95 426
2022/20232.619 280 51 33 175 314 165 4 162 1.276 29 59 71
2023/20241.486 109 46 87 135 411 116 115 38 32 37 107 253
2024/20254.071 18 37 36 157 643 527 488 336 620 591 361 257
2025/202617.016 608 892 941 810 1.421 8.867 1.066 928 573 396 345 169
2026/20272.744 111 429 1.112 1.092 0 0 0 0 0 0 0 0
Totale 32.778